Epac in cardiac calcium signaling

Journal of Molecular and Cellular Cardiology

Volumn 58, Issue 1, 2013, Pages 162-171

  Ruiz Hurtado, Gema ^a,b   Morel, Eric ^a   Domínguez Rodríguez, Alejandro ^a   Llach, Anna ^a   Lezoualc'h, Frank ^c   Benitah, Jean Pierre ^a   Gomez, Ana M ^a  

^a Universite Paris Sud   (France)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Calcium; Epac; Excitation contraction coupling; Excitation transcription coupling; Heart

Indexed keywords

CALCINEURIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CHANNEL; CATECHOLAMINE; CYCLIC AMP BINDING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; EPAC1 PROTEIN; EPAC2 PROTEIN; HISTONE DEACETYLASE 4; MYOCYTE ENHANCER FACTOR 2; RYANODINE RECEPTOR; UNCLASSIFIED DRUG;

CALCIUM CELL LEVEL; CALCIUM DEPLETION; CALCIUM SIGNALING; CALCIUM TRANSPORT; CARDIOVASCULAR FUNCTION; CELL GROWTH; CYTOSOLIC FRACTION; DIASTOLE; EXCITATION CONTRACTION COUPLING; EXCITATION TRANSCRIPTION COUPLING; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; INTRACELLULAR SIGNALING; MEMBRANE DEPOLARIZATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; REVIEW; SYSTOLE; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; CALCIUM; CALCIUM SIGNALING; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CYCLIC AMP; EXCITATION CONTRACTION COUPLING; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM; STRESS, PHYSIOLOGICAL; TYPE C PHOSPHOLIPASES;

RATTUS;

EID: 84876323910     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.11.021     Document Type: Review

References (69)

1. Gloerich M., Bos J.L. Epac: defining a new mechanism for cAMP action. Annu Rev Pharmacol Toxicol 2010, 50:355-375.
2. Lincoln T.M., Komalavilas P., Boerth N.J., MacMillan-Crow L.A., Cornwell T.L. cGMP signaling through cAMP- and cGMP-dependent protein kinases. Adv Pharmacol 1995, 34:305-322.
3. Biel M., Michalakis S. Cyclic nucleotide-gated channels. Handb Exp Pharmacol 2009, 111-136.
4. Houslay M.D. Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown. Trends Biochem Sci 2010, 35:91-100.
5. Enserink J.M., Christensen A.E., de Rooij J., van Triest M., Schwede F., Genieser H.G., et al. A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat Cell Biol 2002, 4:901-906.
6. Holz G.G., Chepurny O.G., Schwede F. Epac-selective cAMP analogs: new tools with which to evaluate the signal transduction properties of cAMP-regulated guanine nucleotide exchange factors. Cell Signal 2008, 20:10-20.
7. Breckler M., Berthouze M., Laurent A.C., Crozatier B., Morel E., Lezoualc'h F. Rap-linked cAMP signaling Epac proteins: compartmentation, functioning and disease implications. Cell Signal 2011, 23:1257-1266.
8. Morel E., Marcantoni A., Gastineau M., Birkedal R., Rochais F., Garnier A., et al. cAMP-binding protein Epac induces cardiomyocyte hypertrophy. Circ Res 2005, 97:1296-1304.
9. Metrich M., Lucas A., Gastineau M., Samuel J.L., Heymes C., Morel E., et al. Epac mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy. Circ Res 2008, 102:959-965.
10. Pereira L., Metrich M., Fernandez-Velasco M., Lucas A., Leroy J., Perrier R., et al. The cAMP binding protein Epac modulates Ca2+ sparks by a Ca2+/calmodulin kinase signalling pathway in rat cardiac myocytes. J Physiol 2007, 583:685-694.
11. Oestreich E.A., Wang H., Malik S., Kaproth-Joslin K.A., Blaxall B.C., Kelley G.G., et al. EPAC-mediated activation of phospholipase C plays a critical role in - adrenergic receptor dependent enhancement of Ca2+ mobilization in cardiac myocytes. J Biol Chem 2007, 282:5488-5495.
12. Oestreich E.A., Malik S., Goonasekera S.A., Blaxall B.C., Kelley G.G., Dirksen R.T., et al. Epac and phospholipase Cepsilon regulate Ca2+ release in the heart by activation of protein kinase Cepsilon and calcium-calmodulin kinase II. J Biol Chem 2009, 284:1514-1522.
13. Ruiz-Hurtado G., Domínguez-Rodríguez A., Pereira L., Fernández-Velasco M., Cassan C., Lezoualc'h F., et al. Sustained Epac activation induces calmodulin dependent positive inotropic effect in adult cardiomyocytes. J Mol Cell Cardiol 2012, 10.1016/j.yjmcc.2012.08.004.
14. Metrich M., Laurent A.C., Breckler M., Duquesnes N., Hmitou I., Courillau D., et al. Epac activation induces histone deacetylase nuclear export via a Ras-dependent signalling pathway. Cell Signal 2010, 22:1459-1468.
15. Pereira L., Ruiz-Hurtado G., Morel E., Laurent A.C., Metrich M., Dominguez-Rodriguez A., et al. Epac enhances excitation-transcription coupling in cardiac myocytes. J Mol Cell Cardiol 2012, 52:283-291.
16. de Rooij J., Zwartkruis F.J., Verheijen M.H., Cool R.H., Nijman S.M., Wittinghofer A., et al. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 1998, 396:474-477.
17. Kawasaki H., Springett G.M., Mochizuki N., Toki S., Nakaya M., Matsuda M., et al. A family of cAMP-binding proteins that directly activate Rap1. Science 1998, 282:2275-2279.
18. Metrich M., Berthouze M., Morel E., Crozatier B., Gomez A.M., Lezoualc'h F. Role of the cAMP-binding protein Epac in cardiovascular physiology and pathophysiology. Pflugers Arch 2010, 459:535-546.
19. Rehmann H., Wittinghofer A., Bos J.L. Capturing cyclic nucleotides in action: snapshots from crystallographic studies. Nat Rev Mol Cell Biol 2007, 8:63-73.
20. Ulucan C., Wang X., Baljinnyam E., Bai Y., Okumura S., Sato M., et al. Developmental changes in gene expression of Epac and its upregulation in myocardial hypertrophy. Am J Physiol Heart Circ Physiol 2007, 293:H1662-H1672.
21. Kang G., Chepurny O.G., Rindler M.J., Collis L., Chepurny Z., Li W.H., et al. A cAMP and Ca2+ coincidence detector in support of Ca2+-induced Ca2+ release in mouse pancreatic beta cells. J Physiol 2005, 566:173-188.
22. Kang G., Joseph J.W., Chepurny O.G., Monaco M., Wheeler M.B., Bos J.L., et al. Epac-selective cAMP analog 8-pCPT-2'-O-Me-cAMP as a stimulus for Ca2+-induced Ca2+ release and exocytosis in pancreatic beta-cells. J Biol Chem 2003, 278:8279-8285.
23. Hothi S.S., Gurung I.S., Heathcote J.C., Zhang Y., Booth S.W., Skepper J.N., et al. Epac activation, altered calcium homeostasis and ventricular arrhythmogenesis in the murine heart. Pflugers Arch 2008, 457:253-270.
24. Cazorla O., Lucas A., Poirier F., Lacampagne A., Lezoualc'h F. The cAMP binding protein Epac regulates cardiac myofilament function. Proc Natl Acad Sci USA 2009, 106:14144-14149.
25. Fabiato A. Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am J Physiol 1983, 245:C1-C14.
26. Bers D.M. Cardiac excitation-contraction coupling. Nature 2002, 415:198-205.
27. Bers D.M. Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol 2008, 70:23-49.
28. Movsesian M.A., Bristow M. Alterations in cAMP-mediated signaling and their role in the pathophysiology of dilated cardiomyopathy. Curr Top Dev Biol 2005, 68:25-48.
29. Osadchii O.E. Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects. Heart Fail Rev 2007, 12:66-86.
30. Dorn G.W., Force T. Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Invest 2005, 115:527-537.
31. Trafford A.W., Diaz M.E., Sibbring G.C., Eisner D.A. Modulation of CICR has no maintained effect on systolic Ca2+: simultaneous measurements of sarcoplasmic reticulum and sarcolemmal Ca2+ fluxes in rat ventricular myocytes. J Physiol 2000, 522(Pt 2):259-270.
32. Reuter H. The dependence of slow inward current in Purkinje fibres on the extracellular calcium-concentration. J Physiol 1967, 192:479-492.
33. Novara M., Baldelli P., Cavallari D., Carabelli V., Giancippoli A., Carbone E. Exposure to cAMP and beta-adrenergic stimulation recruits Ca(V)3 T-type channels in rat chromaffin cells through Epac cAMP-receptor proteins. J Physiol 2004, 558:433-449.
34. Hirano Y., Moscucci A., January C.T. Direct measurement of L-type Ca2+ window current in heart cells. Circ Res 1992, 70:445-455.
35. Fernandez-Velasco M., Ruiz-Hurtado G., Rueda A., Neco P., Mercado-Morales M., Delgado C., et al. RyRCa2+ leak limits cardiac Ca2+ window current overcoming the tonic effect of calmodulinin mice. PLoS One 2011, 6:e20863.
36. Ravindran A., Lao Q.Z., Harry J.B., Abrahimi P., Kobrinsky E., Soldatov N.M. Calmodulin-dependent gating of Ca(v)1.2 calcium channels in the absence of Ca(v)beta subunits. Proc Natl Acad Sci U S A 2008, 105:8154-8159.
37. Bers D.M., Li L., Satoh H., McCall E. Factors that control sarcoplasmic reticulum calcium release in intact ventricular myocytes. Ann N Y Acad Sci 1998, 853:157-177.
38. Balshaw D.M., Xu L., Yamaguchi N., Pasek D.A., Meissner G. Calmodulin binding and inhibition of cardiac muscle calcium release channel (ryanodine receptor). J Biol Chem 2001, 276:20144-20153.
39. Yamaguchi N., Xu L., Pasek D.A., Evans K.E., Meissner G. Molecular basis of calmodulin binding to cardiac muscle Ca(2+) release channel (ryanodine receptor). J Biol Chem 2003, 278:23480-23486.
40. Wu X., Zhang T., Bossuyt J., Li X., McKinsey T.A., Dedman J.R., et al. Local InsP3-dependent perinuclear Ca2+ signaling in cardiac myocyte excitation-transcription coupling. J Clin Invest 2006, 116:675-682.
41. Wu X., Bers D.M. Sarcoplasmic reticulum and nuclear envelope are one highly interconnected Ca2+ store throughout cardiac myocyte. Circ Res 2006, 99:283-291.
42. Bootman M.D., Fearnley C., Smyrnias I., MacDonald F., Roderick H.L. An update on nuclear calcium signalling. J Cell Sci 2009, 122:2337-2350.
43. Humbert J.P., Matter N., Artault J.C., Koppler P., Malviya A.N. Inositol 1,4,5-trisphosphate receptor is located to the inner nuclear membrane vindicating regulation of nuclear calcium signaling by inositol 1,4,5-trisphosphate. Discrete distribution of inositol phosphate receptors to inner and outer nuclear membranes. J Biol Chem 1996, 271:478-485.
44. Gómez AM, Ruiz-Hurtado G, Benitah JP, Domínguez-Rodríguez A. Ca2+ fluxes involvement in gene expression during cardiac hypertrophy. Current Vascular Pharmacology in press.
45. Anderson M.E. Connections count: excitation-contraction meets excitation-transcription coupling. Circ Res 2000, 86:717-719.
46. Backs J., Song K., Bezprozvannaya S., Chang S., Olson E.N. CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J Clin Invest 2006, 116:1853-1864.
47. Backs J., Backs T., Bezprozvannaya S., McKinsey T.A., Olson E.N. Histone deacetylase 5 acquires calcium/calmodulin-dependent kinase II responsiveness by oligomerization with histone deacetylase 4. Mol Cell Biol 2008, 28:3437-3445.
48. Shibasaki F., Price E.R., Milan D., McKeon F. Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4. Nature 1996, 382:370-373.
49. Bare D.J., Kettlun C.S., Liang M., Bers D.M., Mignery G.A. Cardiac type 2 inositol 1,4,5-trisphosphate receptor: interaction and modulation by calcium/calmodulin-dependent protein kinase II. J Biol Chem 2005, 280:15912-15920.
50. Gruver C.L., DeMayo F., Goldstein M.A., Means A.R. Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomyocytes in transgenic mice. Endocrinology 1993, 133:376-388.
51. Suzuki S., Yokoyama U., Abe T., Kiyonari H., Yamashita N., Kato Y., et al. Differential roles of Epac in regulating cell death in neuronal and myocardial cells. J Biol Chem 2010, 285:24248-24259.
52. Yokoyama U., Patel H.H., Lai N.C., Aroonsakool N., Roth D.M., Insel P.A. The cyclic AMP effector Epac integrates pro- and anti-fibrotic signals. Proc Natl Acad Sci USA 2008, 105:6386-6391.
53. Chen C., Du J., Feng W., Song Y., Lu Z., Xu M., et al. beta-Adrenergic receptors stimulate interleukin-6 production through Epac-dependent activation of PKCdelta/p38 MAPK signalling in neonatal mouse cardiac fibroblasts. Br J Pharmacol 2011, 166:676-688.
54. Mika D., Leroy J., Vandecasteele G., Fischmeister R. PDEs create local domains of cAMP signaling. J Mol Cell Cardiol 2011, 52:323-329.
55. Lopez De Jesus M., Stope M.B., Oude Weernink P.A., Mahlke Y., Borgermann C., Ananaba V.N., et al. Cyclic AMP-dependent and Epac-mediated activation of R-Ras by G protein-coupled receptors leads to phospholipase D stimulation. J Biol Chem 2006, 281:21837-21847.
56. Keiper M., Stope M.B., Szatkowski D., Bohm A., Tysack K., Vom Dorp F., et al. Epac- and Ca2+-controlled activation of Ras and extracellular signal-regulated kinases by Gs-coupled receptors. J Biol Chem 2004, 279:46497-46508.
57. Dodge-Kafka K.L., Soughayer J., Pare G.C., Carlisle Michel J.J., Langeberg L.K., Kapiloff M.S., et al. The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature 2005, 437:574-578.
58. Calderon-Sanchez E.M., Ruiz-Hurtado G., Smani T., Delgado C., Benitah J.P., Gomez A.M., et al. Cardioprotective action of urocortin in postconditioning involves recovery of intracellular calcium handling. Cell Calcium 2011, 50:84-90.
59. Calderon-Sanchez E., Delgado C., Ruiz-Hurtado G., Dominguez-Rodriguez A., Cachofeiro V., Rodriguez-Moyano M., et al. Urocortin induces positive inotropic effect in rat heart. Cardiovasc Res 2009, 83:717-725.
60. Ventura-Clapier R., Garnier A., Veksler V., Joubert F. Bioenergetics of the failing heart. Biochim Biophys Acta 2011, 1813:1360-1372.
61. Park S.J., Ahmad F., Philp A., Baar K., Williams T., Luo H., et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 2012, 148:421-433.
62. Benitah J.P., Alvarez J.L., Gomez A.M. L-type Ca(2+) current in ventricular cardiomyocytes. J Mol Cell Cardiol 2010, 48:26-36.
63. Tsai C.T., Lai L.P., Kuo K.T., Hwang J.J., Hsieh C.S., Hsu K.L., et al. Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts: implication for the therapeutic effect of statin in atrial structural remodeling. Circulation 2008, 117:344-355.
64. Reil J.C., Hohl M., Oberhofer M., Kazakov A., Kaestner L., Mueller P., et al. Cardiac Rac1 overexpression in mice creates a substrate for atrial arrhythmias characterized by structural remodelling. Cardiovasc Res 2010, 87:485-493.
65. Adam O., Frost G., Custodis F., Sussman M.A., Schafers H.J., Bohm M., et al. Role of Rac1 GTPase activation in atrial fibrillation. J Am Coll Cardiol 2007, 50:359-367.
66. Liao J.K. Rac1 and connective tissue growth factor. The missing link between atrial remodeling and the pathogenesis of atrial fibrillation?. J Am Coll Cardiol 2010, 55:481-482.
67. Yoshida M., Ohkusa T., Nakashima T., Takanari H., Yano M., Takemura G., et al. Alterations in adhesion junction precede gap junction remodelling during the development f heart failure in cardiomyopathic hamsters. Cardiovasc Res 2011, 92:95-105.
68. Duquesnes N., Derangeon M., Metrich M., Lucas A., Mateo P., Li L., et al. Epac stimulation induces rapid increases in connexin43 phosphorylation and function without preconditioning effect. Pflugers Arch 2010, 460:731-741.
69. Somekawa S., Fukuhara S., Nakaoka Y., Fujita H., Saito Y., Mochizuki N. Enhanced functional gap junction neoformation by protein kinase A-dependent and Epac-dependent signals downstream of cAMP in cardiac myocytes. Circ Res 2005, 97:655-662.